Literature DB >> 17512604

Determination of cerebrospinal fluid concentrations of arginine and dimethylarginines in patients with subarachnoid haemorrhage.

Jens Martens-Lobenhoffer1, Endre Sulyok, Endre Czeiter, Andras Büki, Jana Kohl, Raimund Firsching, Uwe Tröger, Stefanie M Bode-Böger.   

Abstract

Elevated cerebrospinal fluid (CSF) concentrations of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase (NOS), are assumed to be related to delayed vasospasm after subarachnoid haemorrhage (SAH). However, data on CSF concentrations of L-arginine, ADMA and its structural isomer symmetric dimethylarginine (SDMA) are very sparse in humans. We here present a new hydrophilic interaction chromatography-tandem mass spectrometry (HILIC-MS-MS) method for the precise determination of these substances in CSF. The method requires only minimal sample preparation and features isotope labeled internal standards. First data of patients with SAH showed that on the day of admission CSF concentration values of L-arginine and ADMA were not significantly different from controls, but increased markedly during the course of the hospital stay. The decrease of the L-arginine to ADMA ratio points to a progressive impairment of the NO production rate in the brain after SAH which is confirmed by a simultaneous decrease in nitrate and nitrite concentrations in CSF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17512604     DOI: 10.1016/j.jneumeth.2007.04.005

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  8 in total

1.  Hypothermia decreases cerebrospinal fluid asymmetric dimethylarginine levels in children with traumatic brain injury.

Authors:  Bhavani P Thampatty; Megan M Klamerus; Patrick J Oberly; Kerri L Feldman; Michael J Bell; Elizabeth C Tyler-Kabara; P David Adelson; Robert S B Clark; Patrick M Kochanek; Samuel M Poloyac
Journal:  Pediatr Crit Care Med       Date:  2013-05       Impact factor: 3.624

2.  Dimethylarginine levels in cerebrospinal fluid of hyperacute ischemic stroke patients are associated with stroke severity.

Authors:  Raf Brouns; Bart Marescau; Ilse Possemiers; Rishi Sheorajpanday; Peter P De Deyn
Journal:  Neurochem Res       Date:  2009-03-19       Impact factor: 3.996

3.  Intrathecal and systemic alterations of L-arginine metabolism in patients after intracerebral hemorrhage.

Authors:  Marius M Mader; Rainer Böger; Daniel Appel; Edzard Schwedhelm; Munif Haddad; Malte Mohme; Katrin Lamszus; Manfred Westphal; Patrick Czorlich; Juliane Hannemann
Journal:  J Cereb Blood Flow Metab       Date:  2021-01-18       Impact factor: 6.200

Review 4.  Concepts of neural nitric oxide-mediated transmission.

Authors:  John Garthwaite
Journal:  Eur J Neurosci       Date:  2008-06       Impact factor: 3.386

5.  Correlation between plasma total nitric oxide levels and cerebral vasospasm and clinical outcome in patients with aneurysmal subarachnoid hemorrhage in Indian population.

Authors:  Shruthi Shimoga Ramesh; Aripirala Prasanthi; Dhananjaya Ishwar Bhat; Bhagavatula Indira Devi; Rita Cristopher; Mariamma Philip
Journal:  J Neurosci Rural Pract       Date:  2014-11

6.  Dimethylarginines in patients with intracerebral hemorrhage: association with outcome, hematoma enlargement, and edema.

Authors:  Hans Worthmann; Na Li; Jens Martens-Lobenhoffer; Meike Dirks; Ramona Schuppner; Ralf Lichtinghagen; Jan T Kielstein; Peter Raab; Heinrich Lanfermann; Stefanie M Bode-Böger; Karin Weissenborn
Journal:  J Neuroinflammation       Date:  2017-12-13       Impact factor: 8.322

7.  Arginase-1 Released into CSF After Aneurysmal Subarachnoid Hemorrhage Decreases Arginine/Ornithine Ratio: a Novel Prognostic Biomarker.

Authors:  Julian Zimmermann; Johannes Weller; Erdem Güresir; Marcus Müller; Sven Grub; Sied Kebir; Felix Lehmann; Hartmut Vatter; Patrick Schuss
Journal:  Transl Stroke Res       Date:  2021-10-02       Impact factor: 6.800

8.  Endogenous nitric-oxide synthase inhibitor ADMA after acute brain injury.

Authors:  Carla S Jung; Christian Wispel; Klaus Zweckberger; Christopher Beynon; Daniel Hertle; Oliver W Sakowitz; Andreas W Unterberg
Journal:  Int J Mol Sci       Date:  2014-03-06       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.